HIV and AIDS Surveillance
Since January 2008, HIV/AIDS surveillance in Europe has been coordinated by ECDC and the WHO Regional Office for Europe, collecting data on HIV and AIDS from 53 countries of the European region. Surveillance data are reported by nominated contact points in Member States to the European Surveillance System (TESSy). The joint annual HIV/AIDS surveillance report is published in December each year.

• European Network for HIV/AIDS Surveillance
• Surveillance report: HIV/AIDS surveillance in Europe 2011
• Presentation on HIV/AIDS surveillance in Europe 2011
• Surveillance report: HIV/AIDS surveillance in Europe 2010
• Presentation on HIV/AIDS surveillance in Europe 2010
• Surveillance reports archive

STI Surveillance
Since 2009, STI surveillance has been coordinated by ECDC, collecting data on chlamydia, gonorrhoea, syphilis, congenital syphilis and lymphogranuloma venereum. The STI surveillance report describe basic trends and epidemiological features of the five STI under EU surveillance.

• Sexually transmitted infections in Europe 1990-2010
• Sexually transmitted infections in Europe 1990-2009
  

The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)
The European Gonococcal Antimicrobial Surveillance Programme is a sentinel surveillance system. The programme also provides training courses on STI diagnostic methods and includes an external quality assessment (EQA). The STI microbiology project aims to strengthen the surveillance of gonococcal susceptibility.

• Gonococcal antimicrobial susceptibility surveillance in Europe 2010
• Gonococcal antimicrobial susceptibility surveillance in Europe 2009

Hepatitis B and C surveillance
In 2010, ECDC established a new network and a coordination group to prepare and implement enhanced surveillance for hepatitis B and C. In 2011, the first data collection was carried out using revised case definitions and additional variables. The Hepatitis surveillance report includes basic trends and feature of hepatitis B and C in EU/EEA.

• Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies
• Surveillance and prevention of hepatitis B and C in Europe

• Prevention and control of infectious diseases among people who inject drugs
• Prevention and control of infectious diseases among people who inject drugs -  In brief
• Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1
• Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 2

HIV testing guidance
ECDC produced guidance based on the evidence for the individual and public health effects of HIV testing in 2010. The guidance was developed in consultation with stakeholders from Member States, civil society and disease experts.

• HIV testing: increasing uptake and effectiveness in the European Union
• HIV testing: increasing uptake and effectiveness in the European Union. Guidance in brief
• HIV testing: increasing uptake and effectiveness in the European Union. Evidence synthesis for Guidance on HIV testing

Chlamydia control in Europe
A wide range of policies and practices are being implemented by health authorities in Europe to control chlamydia. The ECDC guidance on chlamydia control in Europe 2009 provided a step-wise approach for developing, implementing or improving national strategies for chlamydia control. ECDC aims to monitor on-going progress in chlamydia control and prevention across Europe. 

• ECDC guidance on chlamydia control in Europe

Second generation surveillance refers to surveillance that combines biological and behavioural indicators. In 2009, ECDC published a technical report which presented the current state of STI/HIV behavioural surveillance programmes in Europe and a key set of suggested core and transversal indicators for eight specific sub-populations. These data have been used to produce a toolkit for behavioural surveillance (published on the ECDC website). In a second phase of the project on behavioural surveillance, ECDC provides technical support to countries interested in implementing or improving behavioural surveillance through regional workshops. Technical guidance is being piloted in countries, including a self-assessment tool for the implementation of behavioural surveillance.

• Mapping of HIV/STI behavioural surveillance in Europe
• Behaviour surveillance toolkit

ECDC is carrying out significant work on monitoring the response to the Dublin Declaration on the fight against HIV and AIDS in Europe and Central Asia whilst reducing the reporting burden for countries. In 2010, ECDC published the Progress Report, describing and comparing how countries are responding to HIV, and highlighted key issues for improvement in terms of monitoring the response. In 2012, countries have for the first time reported to ECDC, UNAIDS and WHO using the same online reporting tool. 

• Implementing the Dublin declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: Progress Report
• Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report Summary

Monitoring the EU Action Plan
In 2010, the European Commission mandated ECDC to develop a framework to monitor the implementation of the EU Communication and Action Plan on HIV/AIDS in the EU and Neighbouring Countries 2009-2013, containing policy priorities and 50 actions. 
  

• Monitoring implementation of the European Commission Communication and Action Plan in the EU and Neighbouring countries 2009-2013